iBio Inc
IBIO
Get informed when a big investor buys or sells
+ FollowMarket Cap$22.26M
Close$
$0.13
90.6% downside
Current Fair Value
90.6% downsideOvervalued by 90.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $22.26 Million |
|---|---|
| Enterprise Value | $-21,892,843.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.75 |
| Beta | 1.27 |
| Outstanding Shares | 119,600,000 |
Return
| Return on Equity | -35.60% |
|---|---|
| Return on Assets | -32.16% |
| Return on Invested Capital | -21.01% |
Valuation & Multiples
| P/E Ratio | -2.45 |
|---|---|
| PEG | -4.15 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -72.98 |
| Enterprise Value to EBIT | 1.31 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.16 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 18, 2026
EPS Estimate
$-0.06
Average shareholder expectationRevenue Estimate
$20,000
Average shareholder expectationNext Earnings Call
Expected Date
September 4, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
$80,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 16.24%▼ 0.24% |
|---|---|
| Total Invested | $36.91M▲ 16.97% |
| Investors Holding | 52▲ 3.00% |
ESG Score
No data